Expression and characterization of a soluble rubella virus E1 envelope protein

Area of Science:

• Virology
• Immunology
• Biotechnology

Background:

• Accurate diagnosis of rubella virus (RV) infections and immune status requires specific antigenic proteins.
• The RV envelope glycoprotein E1 is a key target antigen for immune responses, but native forms are difficult to produce and isolate.
• Existing methods for obtaining RV E1 protein face challenges in yield and antigenicity preservation.

Purpose of the Study:

• To develop a method for producing a soluble, highly antigenic rubella virus E1 protein.
• To engineer a modified E1 protein (E1 delta Tm) lacking a transmembrane anchor for improved secretion.
• To evaluate the utility of the produced E1 delta Tm protein for diagnostic assays and vaccine development.

Main Methods:

• Utilized the baculovirus-insect cell expression system to produce a genetically engineered RV E1 protein (E1 delta Tm).
• E1 delta Tm was designed to lack the transmembrane anchor, promoting secretion.
• Employed pulse-chase studies to analyze protein synthesis, glycosylation, and secretion.
• Purified the secreted E1 delta Tm protein using one-step immunochromatography from serum-free medium.

Main Results:

• Successfully produced and secreted abundant soluble E1 delta Tm protein from insect cells.
• The engineered E1 delta Tm protein, lacking a transmembrane anchor, behaved as a secretory protein.
• Purified E1 delta Tm retained full antigenicity, demonstrating its potential as a reliable antigen.
• Demonstrated the feasibility of large-scale production and purification of antigenic E1 protein.

Conclusions:

• The baculovirus-insect cell system provides an effective platform for producing soluble, antigenic rubella virus E1 protein.
• The engineered E1 delta Tm protein is a promising candidate for improving rubella serological diagnostic assays.
• This soluble E1 protein holds potential for future rubella vaccine development, offering a more accessible antigen source.